Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

BACKGROUND: The purpose of this study was to evaluate the efficacy of vildagliptin 50 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73 m(2)) and longstanding type 2 diabetes not adequately controlled with insulin therapy, which is a dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukashevich, Valentina, Schweizer, Anja, Foley, James E, Dickinson, Sheila, Groop, Per-Henrik, Kothny, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559080/
https://www.ncbi.nlm.nih.gov/pubmed/23378769
http://dx.doi.org/10.2147/VHRM.S39300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559080/
https://www.ncbi.nlm.nih.gov/pubmed/23378769
http://dx.doi.org/10.2147/VHRM.S39300

Ejemplares similares